Description

ELTROXIN 125 MG (1X60)

Indications

Eltroxin 125 mg is primarily indicated for the treatment of hypothyroidism, a condition where the thyroid gland does not produce sufficient thyroid hormones. It is also used in the management of goiter, a condition characterized by an enlarged thyroid gland, and in the treatment of certain types of thyroid cancer. Additionally, Eltroxin may be prescribed as a part of a comprehensive treatment plan for patients undergoing thyroid hormone replacement therapy following thyroidectomy.

Mechanism of Action

Eltroxin contains levothyroxine sodium, a synthetic form of the natural thyroid hormone thyroxine (T4). Once administered, levothyroxine is converted to its active form, triiodothyronine (T3), in peripheral tissues. These thyroid hormones play a crucial role in regulating metabolism, growth, and development. They exert their effects by binding to thyroid hormone receptors in the nucleus of cells, leading to the transcription of genes involved in metabolic processes, including carbohydrate metabolism, protein synthesis, and lipid metabolism.

Pharmacological Properties

Levothyroxine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 2 to 4 hours after oral administration. The bioavailability of levothyroxine can be influenced by various factors, including food intake and gastrointestinal health. The drug is highly protein-bound, primarily to thyroxine-binding globulin, and has a long half-life of approximately 7 days, allowing for once-daily dosing. Eltroxin is metabolized mainly in the liver and excreted through urine and feces.

Contraindications

Eltroxin is contraindicated in patients with a known hypersensitivity to levothyroxine or any of the excipients in the formulation. It should not be used in individuals with untreated adrenal insufficiency, as this may precipitate an adrenal crisis. Additionally, patients with thyrotoxicosis or uncorrected hyperthyroidism should not be prescribed Eltroxin, as it can exacerbate these conditions. Caution is also advised in patients with cardiovascular disorders, particularly those with a history of myocardial infarction or angina.

Side Effects

Common side effects associated with Eltroxin may include symptoms of hyperthyroidism such as increased heart rate, anxiety, weight loss, and heat intolerance. Other potential side effects can include insomnia, menstrual irregularities, and gastrointestinal disturbances. Serious adverse effects, although rare, may include cardiac arrhythmias, osteoporosis, and allergic reactions. It is essential for patients to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The dosage of Eltroxin is individualized based on the patient’s age, weight, clinical condition, and laboratory findings. For adults with hypothyroidism, the typical starting dose is 1.6 mcg/kg body weight per day, which may be adjusted based on thyroid function tests. In elderly patients or those with pre-existing cardiovascular conditions, a lower starting dose of 12.5 to 25 mcg per day is recommended. Eltroxin should be taken on an empty stomach, preferably 30 to 60 minutes before breakfast, to enhance absorption. Regular monitoring of thyroid hormone levels is crucial to ensure optimal dosing.

Interactions

Several medications and substances can interact with Eltroxin, potentially altering its effectiveness or increasing the risk of side effects. Antacids, calcium supplements, and iron supplements can reduce the absorption of levothyroxine, necessitating a separation of administration by at least 4 hours. Certain medications, such as rifampin, phenytoin, and sertraline, may increase the metabolism of levothyroxine, requiring dosage adjustments. It is essential for patients to inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with Eltroxin, a thorough medical history and physical examination should be conducted. Patients with a history of cardiovascular disease, diabetes, or adrenal insufficiency require careful monitoring and potential dose adjustments. Pregnant and breastfeeding women should also consult their healthcare provider, as levothyroxine is generally considered safe during pregnancy but may require dosage modifications. Regular follow-up appointments and laboratory tests are essential to assess thyroid function and adjust the dosage as needed.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy and safety of levothyroxine in treating hypothyroidism. A randomized controlled trial published in the Journal of Clinical Endocrinology & Metabolism found that patients receiving levothyroxine exhibited significant improvements in symptoms and quality of life compared to those receiving placebo. Another study highlighted the importance of individualized dosing based on serum TSH levels, emphasizing the need for regular monitoring to achieve optimal therapeutic outcomes. These studies underscore the role of Eltroxin as a cornerstone in the management of thyroid disorders.

Conclusion

Eltroxin 125 mg is a vital therapeutic option for patients with hypothyroidism and other thyroid-related conditions. Its active ingredient, levothyroxine, effectively restores normal thyroid hormone levels, alleviating symptoms and improving overall quality of life. While generally well-tolerated, careful consideration of contraindications, potential side effects, and drug interactions is essential for safe and effective treatment. Ongoing monitoring and individualized dosing are crucial components of successful therapy with Eltroxin.